United States - English - NLM (National Library of Medicine)

sparhawk laboratories, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - gentamicin 5 mg in 1 ml - gentamicin piglet injection is recommended for the treatment of porcine colibacillosis caused by strains of e. coli sensitive to gentamicin. there are no known contraindications to this drug when used as directed.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - gentamicin as gentamicin sulfate - parenteral liquid/solution/suspension - gentamicin as gentamicin sulfate antibiotic active 50.0 mg/ml - antibiotic & related - cat - not pregnant | dog - not pregnant | horse - not pregnant - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmexon consulting s.r.o - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ireland - English - HPRA (Health Products Regulatory Authority)

panpharma - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - gentamicin - solution for injection/infusion - 10 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - gentamicin - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

United States - English - NLM (National Library of Medicine)

stat rx usa llc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - gentamicin sulfate - solution for injection - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

United States - English - NLM (National Library of Medicine)

hospira, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin and other antibacterial drugs, gentamicin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. gentamicin sulfate injection, usp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa , proteus species (indole-positive and indole-negative), escherichia coli , klebsiella-enterobacter-serratia species, citrobacter species, and staphylococcus species (coagulase-positive and coagulase-negative). clinical studies have shown gentamicin sulfate injection, usp to be effective in bacterial neonatal se

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin and other antibacterial drugs, gentamicin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. gentamicin sulfate injection, usp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa , proteus species (indole-positive and indole-negative), escherichia coli , klebsiella-enterobacter-serratia species, citrobacter species, and staphylococcus species (coagulase-positive and coagulase-negative). clinical studies have